Difference between revisions of "Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 (Q9901)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Migden MR, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: DOI Identifier (P138): 10.1056/NEJMoa1805131, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1056/NEJMoa1805131 / rank | |||
| + | Normal rank | ||
Revision as of 19:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Migden MR
0 references
